Q32 Bio Inc
Price
FilingsNewest: 8-K, Regulation FD disclosureSep 30 →Insiders4 insiders bought $30.0M in 4 open-market buys. 3 insiders sold $184,604, 0 of 5 sales on a 10b5-1 plan.→HoldersOrbimed 17.4%Boxer 13.3%Atlas Venture Life Science 11.4%→Financing →PeersClosest companies: CAMP, TECX, ALMS→
From the filings
Figures
- Revenue
- $53.7Mlast 12 months
- Net income
- $33.8Mlast 12 months
- Operating cash flow
- −$27.4Mlast 12 months
- Cash and equivalents
- $106.3Mat the last balance sheet
- Shares outstanding
- 23.7M shareson issue